Hong Qian

Hong Qian is an accomplished professional with extensive experience in investment and product management. Since November 2019, Hong Qian has served as the Director of Investment at Yangtze Investment Limited. At Genscript, where Hong Qian has worked since October 2010, roles include Head of Catalog Product Business Unit, where responsibilities encompass overseeing R&D, production, and marketing activities, as well as strategic planning for both short- and long-term business objectives. In earlier roles, Hong Qian established an automatic production line for protein analysis and contributed to award-winning research on precast PAGE gels. Hong Qian holds a PhD in bioanalytical chemistry from North Carolina State University, earned between 2006 and 2010.